Search Results 751-760 of 16463 for Crohns disease

  1. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  2. Gastroenterology and Hepatology - Clinical trials

    The purpose of the study is to evaluate the efficacy and safety of VR to treat abdominal pain in patients with quiescent Crohn's disease and assess the global ...

  3. Digestive Diseases Clinical Trials - Medical Professionals

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...

  4. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  5. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  6. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    ... Crohn's disease (CD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  7. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  8. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    Long-lasting diarrhea and belly pain could be caused by inflammatory bowel disease, also called IBD. Learn about IBD causes, diagnosis and treatment.

  9. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab To IV/SC Ustekinumab To Assess Change In Crohn's Disease Activity Index (CDAI) In Adult Participants With Moderate To Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab To IV/SC Ustekinumab To Assess Change In Crohn's Disease Activity Index (CDAI) In Adult ...

  10. Mayo Clinic: Patients with Inflammatory Bowel Disease at Higher Risk for Stroke and Heart Attack

    ROCHESTER, Minn. — Oct. 14, 2013 — Patients with inflammatory bowel disease are at an increased risk of stroke and heart attack according to a new study ...